The Uromigos Episode 23: Atezolizumab and Enzalutamide Versus Enzalutamide Prostate Cancer
Chris Sweeney explains why the trial of atezolizumab and enzalutamide in patients with prostate cancer was negative and answers questions raised by the Uromigos.
670 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2022 Mashup Media, LLC. All rights reserved.